AIRLINK 74.00 Increased By ▲ 1.20 (1.65%)
BOP 4.97 Decreased By ▼ -0.09 (-1.78%)
CNERGY 4.36 Increased By ▲ 0.03 (0.69%)
DFML 30.03 Decreased By ▼ -0.49 (-1.61%)
DGKC 90.70 Increased By ▲ 4.75 (5.53%)
FCCL 23.25 Increased By ▲ 0.90 (4.03%)
FFBL 33.70 Increased By ▲ 0.48 (1.44%)
FFL 9.88 Increased By ▲ 0.10 (1.02%)
GGL 10.44 Increased By ▲ 0.04 (0.38%)
HBL 113.20 Decreased By ▼ -0.42 (-0.37%)
HUBC 137.50 Increased By ▲ 1.30 (0.95%)
HUMNL 9.75 Decreased By ▼ -0.28 (-2.79%)
KEL 4.76 Increased By ▲ 0.10 (2.15%)
KOSM 4.79 Increased By ▲ 0.39 (8.86%)
MLCF 39.81 Increased By ▲ 1.46 (3.81%)
OGDC 135.00 Increased By ▲ 1.60 (1.2%)
PAEL 29.19 Increased By ▲ 1.79 (6.53%)
PIAA 24.79 Increased By ▲ 0.03 (0.12%)
PIBTL 7.02 Increased By ▲ 0.47 (7.18%)
PPL 123.15 Increased By ▲ 1.94 (1.6%)
PRL 27.73 Increased By ▲ 0.58 (2.14%)
PTC 14.60 Increased By ▲ 0.71 (5.11%)
SEARL 59.80 Decreased By ▼ -0.60 (-0.99%)
SNGP 69.65 Increased By ▲ 1.12 (1.63%)
SSGC 10.42 Increased By ▲ 0.09 (0.87%)
TELE 8.95 Decreased By ▼ -0.10 (-1.1%)
TPLP 11.56 Increased By ▲ 0.30 (2.66%)
TRG 67.10 Increased By ▲ 1.40 (2.13%)
UNITY 25.26 Increased By ▲ 0.01 (0.04%)
WTL 1.57 Increased By ▲ 0.07 (4.67%)
BR100 7,713 Increased By 79.6 (1.04%)
BR30 25,592 Increased By 419.8 (1.67%)
KSE100 73,310 Increased By 651.7 (0.9%)
KSE30 23,553 Increased By 170 (0.73%)

LONDON: European equities fell in opening deals on Tuesday after the head of Moderna warned current coronavirus vaccines might be less effective at fending off the Omicron variant.

In initial trade, London’s benchmark FTSE 100 index reversed 0.9 percent to 7,047.14 points.

In the eurozone, Frankfurt’s DAX shed 0.9 percent to 15,137.86 points and the Paris CAC 40 lost 1.1 percent to 6,702.83.

Asian bourses and oil prices also took a tumble following the remarks.

Moderna chief executive Stephane Bancel’s comments, in an interview with the Financial Times, sent traders running for cover.

“There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,” he told the daily business newspaper.

The high amount of mutations on Omicron and its swift spread in South Africa indicated the present jabs would need to be tweaked, he indicated.

“Bancel ... predicted existing vaccines would struggle with the Omicron variant,” said CMC Markets analyst Michael Hewson.

The Moderna chief “warned it would take months for pharmaceutical companies to manufacture enough jabs at a sufficient scale to make a difference”, Hewson added.

“His tone contrasts with the likes of Pfizer and BioNTech was suggested any new vaccine would be able to modified fairly quickly.”

Comments

Comments are closed.